Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company. There is currently an urgent need for one study to efficiently test multiple drugs from more than one company, in people who have tested positive for COVID-19 but who do do not currently need hospitalization.
Carolina Clinical Research is currently seeking study participants.
Assess The Efficacy, Safety, And Tolerability Of Itepekimab
This is a study to evaluate the efficacy of Itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD (Chronic Obstructive Pulmonary Disease).
Carolina Clinical Research is currently seeking study participants 40 to 85 years of age with a current COPD diagnosis of at least one year, with a smoking history of greater than or equal to 10 years, but who are not currently smoking.